Ultrafiltration is Associated With Fewer Rehospitalizations than Continuous Diuretic Infusion in Patients With Decompensated Heart Failure: Results From UNLOAD

被引:104
|
作者
Costanzo, Maria Rosa [1 ]
Saltzberg, Mitchell T. [2 ]
Jessup, Mariell
Teerlink, John R. [3 ]
Sobotka, Paul A. [4 ]
机构
[1] Midwest Heart Fdn, Lombard, IL USA
[2] Univ Penn, Dept Med, Div Cardiol, Christiana Hosp, Philadelphia, PA 19104 USA
[3] Univ Calif San Francisco, Cardiol Sect, San Francisco Vet Affairs Med Ctr, Sch Med, San Francisco, CA 94143 USA
[4] Ohio State Univ, Affiliate Fac, Columbus, OH 43210 USA
关键词
Ultrafiltration; diuretics; heart failure; BODY-FLUID; FUROSEMIDE; RESISTANCE; OUTCOMES; REGISTRY; TRIAL; DEATH;
D O I
10.1016/j.cardfail.2009.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Compare outcomes of ultrafiltration (UF) versus standard intravenous (IV) diuretics by continuous infusion or bolus injection in volume overloaded heart failure (HF) patients. In the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated heart Failure (UNLOAD) study, UF produced greater fluid reduction and fewer HF rehospitalizations than IV diuretics in 200 hospitalized HF patients. Outcomes may be due to greater fluid removal, but UF removes more sodium/unit volume than diuretics. Methods and Results: Outcomes of 100 patients randomized to UF were compared with those of patients randomized to standard IV diuretic therapy with continuous infusion (32) or bolus injections (68). Choice of diuretic therapy was by the treating physician. Forty-eight hour weight loss (kg): 5.0 +/- 3.1 UF, 3.6 +/- 3.5 continuous infusion, and 2.9 +/- 3.5 bolus diuretics (P = .001 UF versus bolus diuretic; P > .05 for the other comparisons). Net fluid loss (L): 4.6 +/- 2.6 UF, 3.9 +/- 2.7 continuous infusion, and 3.1 +/- 2.6 bolus diuretics (P < .001 UF versus bolus diuretic; P > .05 for the other comparisons). At 90 days, rehospitalizations plus unscheduled visits for HF/patient (rehospitalization equivalents) were fewer in UF group (0.65 +/- 1.36) than in continuous infusion (2.29 +/- 3.23; P = .016 versus UF) and bolus diuretics (1.31 +/- 1.87; P = .050 versus UF) groups. No serum creatinine differences occurred between groups up to 90 days. Conclusions: Despite similar fluid loss with UF and continuous diuretic infusion, fewer HF rehospitalizations equivalents occurred only with UF. Removal of isotonic fluid by UF compared with hypotonic urine by diuretics more effectively reduces total body sodium in congested HE patients. (J Cardiac Fail 2010;16:277-284)
引用
收藏
页码:277 / 284
页数:8
相关论文
共 50 条
  • [41] Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)
    van Deursen, Vincent M.
    Hernandez, Adrian F.
    Stebbins, Amanda
    Hasselblad, Vic
    Ezekowitz, Justin A.
    Califf, Robert M.
    Gottlieb, Stephen S.
    O'Connor, Christopher M.
    Starling, Randall C.
    Tang, W. H. Wilson
    McMurray, John J.
    Dickstein, Kenneth
    Voors, Adriaan A.
    CIRCULATION, 2014, 130 (12) : 958 - +
  • [42] Progressive Improvement in Cardiac Performance produced by Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results from the MOMENTUM Trial
    Zile, Michael R.
    Colombo, Paolo
    Mehra, Mandeep
    Greenberg, Barry
    Brown, Scott
    Konstam, Marvin
    CIRCULATION, 2008, 118 (18) : S722 - S722
  • [43] Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality
    Goto, Toshihiko
    Wakami, Kazuaki
    Fukuta, Hidekatsu
    Fujita, Hiroshi
    Tani, Tomomitsu
    Ohte, Nobuyuki
    HEART AND VESSELS, 2016, 31 (05) : 734 - 743
  • [44] Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality
    Toshihiko Goto
    Kazuaki Wakami
    Hidekatsu Fukuta
    Hiroshi Fujita
    Tomomitsu Tani
    Nobuyuki Ohte
    Heart and Vessels, 2016, 31 : 734 - 743
  • [45] Low Systolic Blood Pressure at Admission Identifies Patients with Decompensated Heart Failure Who Are Undergoing Slow Continuous Ultrafiltration at High Risk of Short Term Mortality
    Patarroyo, Maria
    Wehbe, Edgard
    Mazen, Hanna
    Demirjian, Sevag
    Tang, W. H. Wilson
    CIRCULATION, 2011, 124 (21)
  • [46] Clinical characteristics associated with diuretic medication in 44,774 patients from the Swedish Heart Failure Registry
    Paren, PPar
    Rosengren, A.
    Edner, M.
    Dahlstrom, U.
    Schaufelberger, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 184 - 185
  • [47] Continuous infusion or bolus injection of loop diuretics for patients admitted for severe acute heart failure: Is one strategy better than the other?
    Caetano, Francisca
    Mota, Paula
    Almeida, Ines
    Fernandes, Andreia
    Botelho, Ana
    Marques, Antonio Leitao
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (02) : 95 - 102
  • [48] Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR)
    Jayagopal, P. B.
    Sastry, Sridhar L.
    Nanjappa, Veena
    Abdullakutty, Jabir
    Joseph, Johny
    Vaidyanathan, P. R.
    Kabra, Nitin
    Manokar, P.
    Ghanta, Soma Sekhar
    Sharma, Vinod
    Mishra, Trinath Kumar
    Jathappa, Narendra
    Singh, Vikas
    Routray, S. N.
    Mandal, Subroto
    Bhalla, Neeraj
    Dorairaj, Prabhakar
    Mehta, Nihar
    Kumbla, Dayanand
    Rane, Abhijit Ramdas
    Matia, Tapan Kumar
    Jain, Dharmendra
    Rege, Gautam
    Modi, Sunil
    Chopra, V. K.
    Mohanan, P. P.
    Zachariah, A. Geevar
    Ravindranath, K. S.
    Chakraborty, Rabin
    Srinivas, B. C.
    Raghu, T. R.
    Manjunath, C. N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 356 : 73 - 78
  • [49] Management of patients with chronic decompensated heart failure: Results from the follow-up serial infusions of nesiritide (FUSION) trial
    Yancy, CW
    Saltzberg, M
    Berkowitz, RL
    Horton, DP
    Silver, MA
    CIRCULATION, 2003, 108 (17) : 694 - 694
  • [50] Troponin Release in Patients Admitted with Acute Decompensated Heart Failure and Renal Dysfunction: Results from the Pilot Phase of the PROTECT Trial
    Metra, Marco
    Dittrich, Howard C.
    Cotter, Gad
    Massie, Barry M.
    Ponikowski, Piotr
    Jia, Gang
    Fujita, Kenji P.
    O'Connor, Christopher M.
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S36 - S37